Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-25
2006-04-25
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S272000, C544S324000, C544S328000
Reexamination Certificate
active
07034031
ABSTRACT:
The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:
REFERENCES:
patent: 4944796 (1990-07-01), Wee
patent: 4997950 (1991-03-01), Murphy et al.
patent: 5932737 (1999-08-01), Itoh et al.
patent: 6048841 (2000-04-01), Baxter et al.
patent: 6306840 (2001-10-01), Adams et al.
patent: 6359061 (2002-03-01), Swayze et al.
patent: 6376538 (2002-04-01), Adams et al.
patent: 2937698 (1981-04-01), None
patent: 0 246 749 (1987-04-01), None
patent: 0 330 959 (1989-02-01), None
patent: 0 372 326 (1989-11-01), None
patent: C 07 D 487/04 (1989-11-01), None
patent: 3928605 (1991-03-01), None
patent: WO 93/17009 (1993-09-01), None
patent: WO 99/00363 (1999-01-01), None
patent: WO 95/12610 (1999-05-01), None
patent: WO 99/28301 (1999-06-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 01/00576 (2001-01-01), None
patent: WO 01/42192 (2001-06-01), None
patent: WO 01/81298 (2001-11-01), None
Graninger et al. Curr. Opin. Rhematol. 13(3) 209-13, 2001.
Shaw et al. Expert Opin. Investig. Drugs 9(7) 1469-1478, 2000.
Waki, et al.“Peptide Synthesis Using the Four-Component Condensation (Ugi Reaction),”J Am Chem Soc., 99(18)6075-6082 (1977).
Tanaka, et al. “Analytical Studies on Mepirizole and its Metabolites. II. Identification of the Human Urinary Metabolites or Mepirizole with Stable Isotope Labeling,”Chem and Pharm Bul., 24(4) 804-807 (1976).
Milata, et al. “2,4,6-Tris(Azol-1-YL)-1,3,5-Triazines: A New Class of Multidentate Ligands,”Heterocycles, 55(5) 905-924 (2001).
Tanaka, et al. “Analytical Studies on Mepirizole and Its Metabolites. III. Gas Chromatographic Determination of Mepirizole and Its Metabolites in Biological Fluids,”Chem and Pharm Bul., 24(4) 808-812 (1976).
Bayer, et al., “Preparation and Properties of Mesoionic Oxazolones,”Chem. Ber., 103(8):2581-2597 (1970). CA 73:77105, 1970. Article and Abstract.
Hazebroucq, G., “2,3,4,5—tetrahydro-H-3-benzazepin-1-ones and hexahydroimidazoisoquinolines,”Ann. Chim(Paris) 1(5/6):221-254 (1966) CA 66:2461, 1966. Article and Abstract.
Graninger, et al., “One-year inhibition of tumor necrosis factor-α: a major success or a larger puzzle?, ”Curr. Opin. Rhematol. 13(3):209-213 (2001).
Shaw, et al., “Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis,”Expert Opin. Investig. Drugs9(7):1469-1478 (2000).
Wrobel, Jay et al., “Synthesis of Tolrestat analogues containing Additional Substituents in the Ring and their Evaluation as Aldose Reductase Inhibitors. Identification of Potent, Orally Active 2-Fluoro Derivatives,”J. Med. Chem. 34:2504-2520 (1991).
Garcia, Jordi et al., “New Synthetic “Tricks”. Triphenylphosphine-Mediated Amide Formation from Carboxylic Acids and Azides,”Tetrahedron Letters, 25(4):4841-4844 (1984).
Coutts, R.T. et al., “Acetylation and pentafluorobenzoylation of lidocaine metabolites in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry,”Biomed. Environ. Mss Specrom. 14(4):173-82 (1987). (FromChem. Abstracts, (1987) 107(5), Abstract No. 32462W).
Kondo, Kazumi et al., “Preparation of amides as vasopressin antagonists, oxytocin antagonists, and vasopressin agonists,” Ohtsuka Pharmaceutical Co., Ltd.) Apr. 19, 1989. (FromChem. Abstracts, (1999) 130(11), Abtract No. 139333g).
Davis, Peter W. et al., “Automated Solid-Phase Synthesis of Linear Nitrogen-Linked Compounds,” Biotechnology and Bioengineering (Combinatorial Chemistry), 19-28, Winter 2000.
Biemann Hans-Peter
Hirth Bradford H.
Kane John L.
Nahill Sharon R.
Qiao Shuang
Balasubramanian Venkataraman
Genzyme Corporation
Hamilton Brook Smith & Reynolds P.C.
LandOfFree
Modulators of TNF-α signaling does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of TNF-α signaling, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of TNF-α signaling will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595839